Bambusa Therapeutics, Inc. Common Stock

BBTX

市值 US$8.01億

15.73 USD

-0.12

0.76%

收盤時已更新 11月6日下午4:00 EST

1天

-0.76%

5天

4.94%

1個月

4.94%

3個月

4.94%

6個月

4.94%

今年迄今

4.94%

1年

4.94%

5年

4.94%

10年

4.94%

關於： Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

醫療保健生物科技

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 100%

負面 0%

中性

Seeking Alpha

8 天前

U.S. IPO Weekly Recap: Anthropic Files For Potentially Record-Breaking IPO

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.

查看新聞排名

價格圖表採用Lightweight Charts™實作

Bambusa Therapeutics, Inc. Common Stock BBTX 市值 US$8.01億

新聞

Bambusa Therapeutics, Inc. Common Stock

BBTX

市值 US$8.01億